A part of Merck

203641 | BMP-2, Human, Recombinant, E. coli

203641
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmarDisponibilidad a confirmar
En existencia 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Ver precios y disponibilidad
      Click To Print This Page

      Descripción

      Replacement Information

      Tabla espec. clave

      Purity
      ≥95% by SDS-PAGE

      Precios y disponibilidad

      Número de referenciaDisponiblidad Embalaje Cant./Env. Precio Cantidad
      US1203641-2UG
      Comprobando disponibilidad...
      Disponibilidad a confirmarDisponibilidad a confirmar
      En existencia 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente

          Frasco de vidrio 2 μg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          Description
          OverviewRecombinant, human bone morphogenetic protein-2 (BMP-2) expressed in E. coli and purified by proprietary chromatographic methods. BMP-2 is a homodimeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-2 is known to regulate diverse fundamental processes during embryonic development. It also plays an important role in cardiac morphogenesis and is expressed in a variety of tissues such as lung, spleen, brain, liver, prostate, ovary, and small intestine.
          Catalogue Number203641
          Brand Family Calbiochem®
          SynonymsBone morphogenetic protein 2 precursor, BMP-2A
          References
          ReferencesCsiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
          Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
          Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
          Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
          Morin, R., et al. 2006. Biomacromolecules 7, 131.
          Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.
          Product Information
          FormLyophilized
          FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
          Applications
          Biological Information
          Purity≥95% by SDS-PAGE
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Blue Ice Only
          Toxicity Standard Handling
          Storage -20°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Certificados de análisis

          CargoNúmero de lote
          203641

          Referencias bibliográficas

          Visión general referencias
          Csiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
          Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
          Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
          Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
          Morin, R., et al. 2006. Biomacromolecules 7, 131.
          Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.
          Ficha técnica

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision20-May-2008 RFH
          SynonymsBone morphogenetic protein 2 precursor, BMP-2A
          DescriptionRecombinant, human bone morphogenetic protein-2 (BMP-2) expressed in E. coli and purified by proprietary chromatographic methods. BMP-2 is a homodimeric protein that belongs to the transforming growth factor-β (TGF-β) superfamily. BMP-2 is known to regulate diverse fundamental processes during embryonic development. It also plays an important role in cardiac morphogenesis and is expressed in a variety of tissues such as lung, spleen, brain, liver, prostate, ovary, and small intestine.
          FormLyophilized
          FormulationLyophilized from sterile 10 mM sodium citrate, pH 3.5.
          Purity≥95% by SDS-PAGE
          SolubilityReconstitute to ≥100 µg/ml with 20 mM acetic acid containing 0.1% HSA or BSA. Further dilutions can be made in aqueous buffers just prior to use.
          Storage -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for 2-7 days at 4°C or for up to 6 months at -20°C. Avoid freeze/thaw cycles of solutions.
          Toxicity Standard Handling
          ReferencesCsiszar, A., et al. 2006. Am. J. Pathol. 168, 629.
          Kumagai, T., et al. 2006. Anticancer Res. 26, 293.
          Kumagai, T., et al. 2006. Int. J. Mol. Med. 17, 285.
          Kuo, P.L., et al. 2006. Biol. Pharm. Bull. 29, 119.
          Morin, R., et al. 2006. Biomacromolecules 7, 131.
          Villavicencio, A.T., et al. 2005. J. Neurosurg. Spine 3, 436.